Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000902664-25-001328
Filing Date
2025-03-03
Accepted
2025-03-03 21:31:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3770
  Complete submission text file 0000902664-25-001328.txt   5820
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Subject) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37686 | Film No.: 25701207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006
Business Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 (345) 749-8643
HHLR ADVISORS, LTD. (Reporting) CIK: 0001762304 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144